| STOCKHOLDERS’ EQUITY |
NOTE
11 – STOCKHOLDERS’ EQUITY
Preferred
stock
The
Company is authorized to issue 50,000,000 shares of Preferred Stock. Each share of Preferred Stock has the voting power of ten shares
of Common Stock, and can at any time be converted into five (5), shares of Common Stock. The table below sets forth the number of shares
of Preferred Stock issued and outstanding during the reporting period(s). There were 43,283,991 Preferred Stock outstanding on June 30,
2026:
Issuances
of Preferred Stock in the period January 1 and June 30, 2025
SCHEDULE OF PREFERRED STOCK ISSUED AND OUTSTANDING
| Date |
|
|
#
Shares |
|
|
Amount |
|
|
Price/Share |
|
|
Type |
|
Notice |
|
| 1/01/2025 |
|
|
|
43,158,248 |
|
|
$ |
4,408,582 |
|
|
$ |
0.102 |
|
|
|
|
|
|
| 1/10/2025 |
b |
|
|
(150,000 |
) |
|
|
(750 |
) |
|
|
0.005 |
|
|
Stock
conversion |
|
affiliate |
|
| 3/31/2025 |
|
|
|
— |
|
|
|
214,780 |
|
|
|
— |
|
|
Payroll
forfeiture* |
|
affiliate |
|
| See
Note 12 |
d |
|
|
421,391 |
|
|
|
153,342 |
|
|
|
0.364 |
|
|
2021
Stock Plan |
|
affiliate |
|
| 6/30/2025 |
|
|
|
43,429,639 |
|
|
$ |
4,774,544 |
|
|
$ |
0.110 |
|
|
|
|
|
|
There
has been no issuance of Preferred Stock in the period January 1 and June 30, 2026
| Date |
|
|
#
Shares |
|
|
Amount |
|
|
Price/Share |
|
|
Type |
|
Notice |
|
| 6/30/2026 |
|
|
|
43,283,991 |
|
|
$ |
4,748,150 |
|
|
$ |
0.110 |
|
|
|
|
|
|
| * |
The
transaction originating from the Company’s Officers forfeiting $578,959 of accrued payroll in the first quarter of 2025. |
Common
stock
The
Company is authorized to issue 400,000,000 shares of Common Stock. There were 114,695,219 Common Stock outstanding on June 30, 2026:
Issuances
of Common Stock in the period January 1 and June 30, 2025
SCHEDULE OF COMMON STOCK ISSUED AND OUTSTANDING
| Date |
|
|
#
Shares |
|
|
Amount |
|
|
Price/Share |
|
|
Type |
|
Notice |
|
| 1/01/2025 |
|
|
|
86,782,908 |
|
|
$ |
12,722,039 |
|
|
$ |
0.147 |
|
|
|
|
|
|
| 1/10/2025 |
d |
|
|
750,000 |
|
|
|
750 |
|
|
|
0.001 |
|
|
Stock
conversion |
|
|
|
| see
Note 12 |
d |
|
|
1,409,335 |
|
|
|
106,754 |
|
|
|
0.073 |
|
|
2021
Stock Plan |
|
|
|
| b |
|
|
|
88,942,243 |
|
|
$ |
12,829,543 |
|
|
$ |
0.144 |
|
|
|
|
|
|
Issuances
of Common Stock in the period January 1 and June 30, 2026
| Date |
|
|
#
Shares |
|
|
Amount |
|
|
Price/Share |
|
|
Type |
|
Notice |
|
| 1/01/2026 |
|
|
|
108,147,731 |
|
|
$ |
13,607,433 |
|
|
$ |
0.126 |
|
|
|
|
|
|
| 1/23/2026 |
a |
* |
|
4,716,000 |
|
|
|
145,701 |
|
|
|
0.031 |
|
|
private
placement |
|
|
|
| 1/23/2026 |
a |
* |
|
— |
|
|
|
95,339 |
|
|
|
— |
|
|
warrants |
|
|
|
| 1/10/2026 |
c |
|
|
75,000 |
|
|
|
5,550 |
|
|
|
0.074 |
|
|
consulting
fees |
|
|
|
| 2/10/2026 |
c |
|
|
239,155 |
|
|
|
10,723 |
|
|
|
0.046 |
|
|
consulting
fees |
|
|
|
| 3/10/2026 |
c |
|
|
184,000 |
|
|
|
8,150 |
|
|
|
0.044 |
|
|
consulting
fees |
|
|
|
| 5/08/2026 |
a |
† |
|
1,333,334 |
|
|
|
45,453 |
|
|
|
0.040 |
|
|
private
placement |
|
|
|
| 5/08/2026 |
a |
† |
|
|
|
|
|
28,147
|
|
|
|
— |
|
|
warrants |
|
|
|
| 6/30/2026 |
|
|
|
114,695,220 |
|
|
$ |
13,946,496 |
|
|
$ |
0.122 |
|
|
|
|
|
|
Common
Shares due, but not yet issued in accordance with service contract at June 30, 2026:
| Date |
|
|
#
Shares |
|
|
Amount |
|
|
Price/Share |
|
|
Type |
|
Notice |
|
| 1/01/2026 |
a |
|
|
75,000 |
|
|
$ |
4,883 |
|
|
$ |
0.065 |
|
|
consulting
fees |
|
|
|
| 5/08/2026 |
a |
† |
|
106,667 |
|
|
|
— |
|
|
|
— |
|
|
commission |
|
|
|
| 6/30/2026 |
a |
|
|
661,770 |
|
|
|
22,593 |
|
|
|
0.034 |
|
|
consulting
fees |
|
|
|
| 6/30/2026 |
|
|
|
843,437 |
|
|
$ |
27,476 |
|
|
$ |
0.033 |
|
|
|
|
|
|
| * |
Around
January 23, 2026, the Company proposed a private placement offering investors to purchase shares and warrants issued together as
a unit; however, each warrant is detachable and separately exercisable to purchase one share of Common Stock. The average price was
$0.06 per unit, less a broker (Member FINRA / SIPC) fee consisting of 8% cash commission and 8% bonus shares. The Company raised
a total of $241,040 (after $20,960 cash commission) and issued 4,716,000 shares of Common Stock (after 349,333 bonus shares), as
well as 4,366,667 5-year warrants exercisable to buy Common Stock at $0.12 per share. The net received by the Company was $0.053
per unit. |
| † |
Around
May 8, 2026, the Company proposed a private placement offering investors to purchase shares and warrants issued together as a unit;
however, each warrant is detachable and separately exercisable to purchase one share of Common Stock. The average price was $0.06
per unit, less a broker (Member FINRA / SIPC) fee consisting of 8% cash commission and 8% bonus shares. The Company raised a total
of $73,600 (after $6,400 cash commission) and issued 1,440,001 shares of Common Stock (after 106,667 bonus shares), as well as 1,333,334
5-year warrants exercisable to buy Common Stock at $0.12 per share. The net received by the Company was $0.053 per unit. |
| a |
The
Company claims an exemption from the registration requirements of the Securities Act for the private placement of these securities
pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated under the Securities Act. |
| b |
The
Company claims an exemption from the registration requirements of the Securities Act pursuant to the exchange exemption under Rule
144 of the Securities Act. |
| c |
The
Company claims an exemption from the registration requirements of the Securities Act pursuant to the exchange exemption in Rule 3(a)(9)
of the Securities Act. |
| d |
The
Company claims an exemption from the registration requirements of the Securities Act for the compensatory benefit plan pursuant to
Rule 701 of the Securities Act. |
Common
Stock Warrants
The
fair value of Common Stock warrants granted for the six months ended June 30, 2026, and June 30, 2025 was calculated with the following
assumptions:
SCHEDULE OF STOCK WARRANTS VALUATION ASSUMPTIONS
| |
|
June
30, 2026 |
|
|
June
30, 2025 |
|
| Risk-free
interest rate |
|
|
3.92
– 4.02 |
% |
|
|
3.96
– 4.61 |
% |
| Expected
dividend yield |
|
|
0 |
% |
|
|
0 |
% |
| Volatility
factor (monthly) |
|
|
118.17 |
% |
|
|
127.02 |
% |
| Expected
life of warrant |
|
|
5
years |
|
|
|
5
years |
|
For
the six months ended June 30, 2026, the Company issued 5,700,001 warrants. For the six months ended June 30, 2025, the Company did not
award any warrants.
The
following table summarizes the Company’s Common Stock warrant activity for the six months ended June 30, 2026, and 2025:
SCHEDULE OF COMMON STOCK WARRANT ACTIVITY
| | |
|
Number of Warrants * | | |
Weighted Average Exercise Price | | |
Weighted Average Remaining Expected Term | |
| Outstanding as at January 1, 2025 | |
|
| 1,292,030 | | |
$ | 0.22 | | |
| 2.6 | |
| Granted | |
|
| — | | |
| — | | |
| — | |
| Exercised | |
|
| — | | |
| — | | |
| — | |
| Forfeited/Cancelled | |
|
| — | | |
| — | | |
| — | |
| Outstanding as at June 30, 2025 | |
|
| 1,292,030 | | |
$ | 0.22 | | |
| 2.7 | |
| | |
|
| | | |
| | | |
| | |
| Outstanding as at January 1, 2026 | |
|
| 16,675,364 | | |
$ | 0.13 | | |
| 4.6 | |
| Granted | |
|
| 5,700,001 | | |
| 0.12 | | |
| 5.0 | |
| Exercised | |
|
| — | | |
| — | | |
| — | |
| Forfeited/Cancelled | |
|
| — | | |
| — | | |
| — | |
| Outstanding as at June 30, 2026 | |
|
| 22,375,365 | | |
$ | 0.13 | | |
| 4.3 | |
The
following table summarizes information about stock warrants that are vested or expected to vest at June 30, 2026, with a market price
of $0.045 at June 30, 2026:
SCHEDULE OF WARRANT OUTSTANDING AND EXERCISABLE WARRANTS
| |
|
|
|
|
|
Warrants
Outstanding and Exercisable |
|
|
|
|
| Exercise
Price |
|
|
Number
of Warrants |
|
|
Weighted
Average
Exercise
Price
Per
Share |
|
|
Weighted
Average
Remaining
Contractual
Life
(Years) |
|
|
Aggregate
Intrinsic
Value |
|
| $ |
0.12 |
|
|
|
21,083,335 |
|
|
$ |
0.12 |
|
|
|
4.7 |
|
|
$ |
— |
|
| |
0.20-0.25 |
|
|
|
1,264,030 |
|
|
|
0.23 |
|
|
|
1.7 |
|
|
|
— |
|
| |
0.47 |
|
|
|
28,000 |
|
|
|
0.47 |
|
|
|
1.4 |
|
|
|
— |
|
| $ |
0.12-0.47 |
|
|
|
22,375,365 |
|
|
$ |
0.13 |
|
|
|
4.3 |
|
|
$ |
— |
|
The
weighted-average remaining contractual life for warrants exercisable at June 30, 2026, is 4.2 years. The aggregate intrinsic value for
fully vested, exercisable warrants was $0 at June 30, 2026.
|